Acrivon Therapeutics (ACRV) Earnings Date, Estimates & Call Transcripts → Radical change coming — do this NOW to protect yourself (From Weiss Ratings) (Ad) Free ACRV Stock Alerts $7.08 -0.17 (-2.34%) (As of 12:33 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 9EstimatedActual EPS (May. 14) -$0.73 Beat By $0.16 Consensus EPS (May. 14) -$0.89 Get Acrivon Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACRV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACRV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACRV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsAre you prepared for a financial lockdown?A new kind of American dystopia is being built before our eyes, and most people have no idea what's happening. That's why I've recorded this urgent message to give you all the details on how to prepare … Including three steps to take right now.Click here to watch my video before it's too late. Acrivon Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.89)($0.89)($0.89)Q2 20241($0.48)($0.48)($0.48)Q3 20241($0.49)($0.49)($0.49)Q4 20241($0.54)($0.54)($0.54)FY 20244($2.40)($2.40)($2.40)ACRV Earnings Date and InformationAcrivon Therapeutics last issued its quarterly earnings data on May 14th, 2024. The reported ($0.73) EPS for the quarter, beating analysts' consensus estimates of ($0.89) by $0.16. Acrivon Therapeutics has generated ($2.88) earnings per share over the last year (($2.88) diluted earnings per share). Earnings for Acrivon Therapeutics are expected to decrease in the coming year, from ($2.47) to ($2.55) per share. Acrivon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.Read More Acrivon Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/9/2024(Estimated)------- 5/14/2024Q1 2024($0.89)($0.73)+$0.16($0.73)--3/28/2024Q4 2023($0.72)($0.86)($0.14)($0.86)--11/9/2023Q3 2023($0.72)($0.66)+$0.06($0.66)--8/11/2023Q2 2023($0.65)($0.63)+$0.02($0.63)--5/9/2023Q1 2023($0.64)($0.58)+$0.06($0.58)--3/28/2023Q4 2022($1.10)($0.80)+$0.30($0.80)-- Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/2022Q3 2022($2.44)($5.17)($2.73)($5.17)-- Acrivon Therapeutics Earnings - Frequently Asked Questions When is Acrivon Therapeutics's earnings date? Acrivon Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on ACRV's earnings history. Did Acrivon Therapeutics beat their earnings estimates last quarter? In the previous quarter, Acrivon Therapeutics (NASDAQ:ACRV) reported ($0.73) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.89) by $0.16. Learn more on analysts' earnings estimate vs. ACRV's actual earnings. How much profit does Acrivon Therapeutics generate each year? Acrivon Therapeutics (NASDAQ:ACRV) has a recorded net income of -$60.39 million. ACRV has generated -$2.88 earnings per share over the last four quarters. What is Acrivon Therapeutics's EPS forecast for next year? Acrivon Therapeutics's earnings are expected to decrease from ($2.47) per share to ($2.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Cassava Sciences Earnings Results Arcutis Biotherapeutics Earnings Results Arcturus Therapeutics Earnings Results ARS Pharmaceuticals Earnings Results 89bio Earnings Results Cogent Biosciences Earnings Results Stoke Therapeutics Earnings Results Nurix Therapeutics Earnings Results Aurinia Pharmaceuticals Earnings Results Ocular Therapeutix Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:ACRV) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.